Digital Sponsored The content velocity trap: Why producing more is making your... Viseven explores how to fix the broken upstream engagement strategy process without losing even more time, resources, and effort in the process.
Market Access Is AI the missing link in fixing MLR – or the reason it brea... Somewhere in a shared drive at a mid-size pharma company, there is a folder labelled “Q3 Messaging FINAL v3 (2).” Inside it are three Word documents with tracked changes from four people, n
Digital Sponsored Accelerating the content lifecycle: A 7-step guide for AI in... By integrating AI agents into medical, legal, and regulatory (MLR) processes, organisations can transform content lifecycle management.
Digital Sponsored Is AI the missing link in fixing the broken MLR process? Marketing teams often wait up to two months for medical legal regulatory (MLR) feedback.
Digital Veeva Commercial Summit: On AI, content, and MLR Review with... At Veeva Commercial Summit 2025 in Madrid, web editor Nicole Raleigh sat down with Emma Hyland – Vice President, Commercial Content Strategy, Europe.
Digital How to fix pharma's content duplication problem At the heart of every pharma company lies a big problem: medical affairs and commercial teams are independently creating the same content.
Oncology ASCO 2026: Chinese firms take a front seat in oncology, with... Dr Li Mao and Dr Giovanni Selvaggi of Betta Pharmaceuticals and Xcovery Holdings discuss their novel ALK inhibitor and the Chinese biotech landscape.
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.